Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Acute Pain × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 5 Pain 2 Chronic Pain 2 Breast Neoplasms 2 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neuralgia 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Cancer Patient 1 Brain Neoplasms 1 Astrocytoma 1 Acute Pain 1

Interventions

Ketamine 2 Diclofenac 2 Anesthesia, General 2 Acetaminophen 2 Tea 1 Quality of Life 1 Pregabalin 1 Passive Cutaneous Anaphylaxis 1 Oxycodone 1 Minocycline 1 Meloxicam 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Hydromorphone 1 Gabapentin 1 Ethyl Chloride 1 Epinephrine 1 Duloxetine Hydrochloride 1 Diathermy 1 Cryotherapy 1 Bupivacaine 1 Anti-Inflammatory Agents, Non-Steroidal 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed

Lymphoma, Follicular, Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡